Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Sclafani · SciRah

Researcher profile · Semantic Scholar

F. Sclafani

Share profile

F. Sclafani — researcher profile on SciRah

h-index: 32
Works: 166
Citations: 4,296

Most-cited papers

European evidence-based guidelines on pancreatic cystic neoplasms
M. del Chiaro, M. Besselink, Lianne Scholten, M. Bruno +85 more
2018Gut1,182 citations Open access
Semantic Scholar
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer
A. Woolston, K. Khan, G. Spain, L. Barber +35 more
2018bioRxiv235 citations Open access
Semantic Scholar
Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer
F. Sclafani, Gina Brown, D. Cunningham, A. Wotherspoon +12 more
2017British Journal of Cancer182 citations Open access
Semantic Scholar
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct.
S. Rao, F. Sclafani, C. Eng, Richard A. Adams +17 more
2020Journal of Clinical Oncology121 citations Open access
Semantic Scholar
New therapeutic targets in pancreatic cancer.
E. Lai, M. Puzzoni, P. Ziranu, A. Pretta +15 more
2019Cancer Treatment Reviews85 citations Open access
Semantic Scholar
Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016
Aviv Ladanie, A. Schmitt, B. Speich, F. Naudet +12 more
2020JAMA Network Open84 citations Open access
Semantic Scholar
PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.
F. Sclafani, G. Brown, D. Cunningham, A. Wotherspoon +12 more
2016Annals of Oncology82 citations Open access
Semantic Scholar
Treatment and Survival Outcome of BRAF‐Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case‐Control Study
H. Kayhanian, E. Goode, F. Sclafani, J. Ang +9 more
2017Clinical colorectal cancer60 citations
Semantic Scholar
Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials.
E. Giunta, G. Bregni, A. Pretta, A. Deleporte +7 more
2021Cancer Treatment Reviews59 citations
Semantic Scholar
Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients
F. Sclafani, S. H. Wilson, D. Cunningham, David Gonzalez de Castro +11 more
2019International Journal of Cancer57 citations Open access
Semantic Scholar
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
F. Sclafani, I. Chau, D. Cunningham, J. Hahne +18 more
2018Scientific Reports57 citations Open access
Semantic Scholar
Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer.
H. Mohan, E. Ryan, I. Balasubramanian, R. Kennelly +12 more
2016European Journal of Surgical Oncology56 citations
Semantic Scholar
PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.
T. Telli, G. Bregni, S. Camera, A. Deleporte +2 more
2020Cancer Letters50 citations
Semantic Scholar
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes
C. Ragulan, K. Eason, E. Fontana, G. Nyamundanda +16 more
2019Scientific Reports41 citations Open access
Semantic Scholar
Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer.
Tuğba Akın Telli, G. Bregni, Michele Vanhooren, Rita Saude Conde +2 more
2022Cancer Treatment Reviews39 citations
Semantic Scholar
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study
David Lau, E. Kalaitzaki, D. Church, H. Pandha +13 more
2020ESMO Open39 citations Open access
Semantic Scholar
PD-1 inhibition in metastatic dMMR/MSI-H colorectal cancer.
F. Sclafani
2017The Lancet Oncology38 citations
Semantic Scholar
Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients.
F. Sclafani, F. Morano, D. Cunningham, C. Baratelli +5 more
2017The Oncologist37 citations Open access
Semantic Scholar
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage
P. Carotenuto, Francesco Amato, A. Lampis, Colin Rae +34 more
2021Nature Communications31 citations Open access
Semantic Scholar
Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study
E. Alouani, M. Mercier, C. Flecchia, É. Auclin +20 more
2023ESMO Open28 citations Open access
Semantic Scholar
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer
Ewa Wrona, P. Potemski, F. Sclafani, M. Borowiec
2021Archivum Immunologiae et Therapiae Experimentalis26 citations Open access
Semantic Scholar
Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies.
Aviv Ladanie, B. Speich, M. Briel, F. Sclafani +6 more
2019Journal of Clinical Epidemiology23 citations Open access
Semantic Scholar
Systemic Therapies for Advanced Squamous Cell Anal Cancer
F. Sclafani, S. Rao
2018Current Oncology Reports23 citations
Semantic Scholar
Bratislava Statement: consensus recommendations for improving pancreatic cancer care
J. Prades, D. Arnold, T. Brunner, A. Cardone +17 more
2020ESMO Open21 citations Open access
Semantic Scholar
Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer
F. Sclafani, Claudia Corrò, T. Koessler
2021Cancers18 citations Open access
Semantic Scholar
Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases
Antoine el Asmar, Martin Delcourt, Leonel Kamden, Charif Khaled +5 more
2022Annals of Surgical Oncology16 citations Open access
Semantic Scholar
Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review
F. Sclafani, Gina Hesselberg, S. Thompson, P. Truskett +3 more
2019Journal of Surgical Oncology16 citations
Semantic Scholar
Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients
F. Sclafani, I. Chau, D. Cunningham, A. Lampis +18 more
2016Carcinogenesis16 citations Open access
Semantic Scholar
Fat density is a novel prognostic marker in patients with esophageal cancer.
Maelle Anciaux, A. Van Gossum, C. Wenglinski, L. Ameye +8 more
2020Clinical Nutrition ESPEN15 citations
Semantic Scholar
Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives
N. Personeni, V. Smiroldo, E. Giunta, M. G. Prete +3 more
2021Cancers14 citations Open access
Semantic Scholar
The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs
Aviv Ladanie, B. Speich, F. Naudet, A. Agarwal +9 more
2018Trials14 citations Open access
Semantic Scholar
Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance
Pashalina Kehagias, N. Kindt, Mohammad Krayem, Ahmad Najem +8 more
2022Cells13 citations Open access
Semantic Scholar
Duration of first-line treatment for metastatic colorectal cancer: Translating the available evidence into general recommendations for routine practice.
F. Morano, F. Sclafani
2018Critical reviews in oncology/hematology13 citations
Semantic Scholar
Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.
F. Sclafani, Gina Brown, D. Cunningham, S. Rao +10 more
2017The Oncologist13 citations Open access
Semantic Scholar
Pre-trial quality assurance of diffusion-weighted MRI for radiomic analysis and the role of harmonisation.
Z. Paquier, Shih-Li Chao, G. Bregni, A. V. Sánchez +7 more
2022Physica medica (Testo stampato)12 citations Open access
Semantic Scholar
POLEM: Avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III dMMR or POLE exonuclease domain mutant colon cancer—A phase III randomized study.
David K. Lau, D. Cunningham, A. Gillbanks, R. Crux +11 more
2019Journal of Clinical Oncology11 citations
Semantic Scholar
Buschke-Löwenstein tumor in a human immunodeficiency virus-positive patient: a case report and short literature review.
V. Ledouble, F. Sclafani, A. Hendlisz, M. G. Galdon +1 more
2021Acta gastro-enterologica Belgica10 citations Open access
Semantic Scholar
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer
G. Bregni, C. Vandeputte, A. Pretta, C. Senti +21 more
2021Acta oncologica10 citations Open access
Semantic Scholar
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial
S. Camera, Tuğba Akın Telli, E. Woff, C. Vandeputte +16 more
2020Cancers10 citations Open access
Semantic Scholar
Neoadjuvant rectal score: run with the hare and hunt with the hounds.
F. Sclafani, E. Kalaitzaki, D. Cunningham, D. Tait +2 more
2018Annals of Oncology10 citations Open access
Semantic Scholar
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer
E. Woff, L. Salvatore, F. Marmorino, D. Genovesi +6 more
2021Journal of Nuclear Medicine9 citations Open access
Semantic Scholar
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer.
S. Partelli, F. Sclafani, S. Barbu, Marc Beishon +19 more
2021Cancer Treatment Reviews9 citations
Semantic Scholar
Molecular subtype assay to reveal anti-EGFR response sub-clones in colorectal cancer (CRC).
E. Fontana, G. Nyamundanda, D. Cunningham, C. Ragulan +11 more
20189 citations
Semantic Scholar
Circulating DNA in the neoadjuvant setting of early stage colon cancer
G. Bregni, A. Pretta, C. Senti, Elena Acedo Reina +22 more
2022Acta oncologica8 citations Open access
Semantic Scholar
MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast Cancer.
S. Camera, A. Deleporte, G. Bregni, Elena Trevisi +10 more
2020Clinical colorectal cancer8 citations
Semantic Scholar
MEK and PD-L1 inhibition in colorectal cancer: a burning blaze turning into a flash in the pan.
F. Sclafani
2019The Lancet Oncology8 citations
Semantic Scholar
Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial
F. Sclafani, T. Y. Kim, D. Cunningham, T. W. Kim +15 more
2017International Journal of Cancer8 citations Open access
Semantic Scholar
The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study
Antoine el Asmar, P. Demetter, F. Fares, F. Sclafani +4 more
2023Annals of Surgical Oncology7 citations Open access
Semantic Scholar
Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial
E. Fontana, G. Nyamundanda, D. Cunningham, D. Tu +22 more
2020JCO Precision Oncology7 citations Open access
Semantic Scholar
Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer
Maelle Anciaux, P. Demetter, R. De Wind, M. Gomez-Galdón +11 more
2020BMJ Open Gastroenterology7 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Cunningham×15
Invite
D. Cunningham — researcher profile on SciRah
I. Chau×13
Invite
I. Chau — researcher profile on SciRah
A. Hendlisz×13
Invite
A. Hendlisz — researcher profile on SciRah
R. Begum×10
Invite
R. Begum — researcher profile on SciRah

×10

Invite

G. Bregni — researcher profile on SciRah

Invite

N. Starling — researcher profile on SciRah

A. Wotherspoon×8

Invite

A. Wotherspoon — researcher profile on SciRah

Invite

S. Rao — researcher profile on SciRah

A. Deleporte×8

Invite

A. Deleporte — researcher profile on SciRah

Invite

C. Peckitt — researcher profile on SciRah

E. Kalaitzaki×7

Invite

E. Kalaitzaki — researcher profile on SciRah

Invite

D. Watkins — researcher profile on SciRah